New User:

Forgot your password?

Stock Market & Financial Investment News

News Breaks
January 8, 2013
07:07 EDTELOSSyneron Medical says Syneron Beauty poised to break even in 1Q, says Cantor
After meeting with Syneron's management, Cantor reports that the company expects its Syneron Beauty segment to break even this quarter. The firm thinks the company is poised to report "meaningful profitability" this year, and it reiterates a $16 price target and Buy rating on the stock.
News For ELOS From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
June 25, 2015
07:01 EDTELOSSyneron Medical announces results of clinical trial for Profound
Syneron Medical released the results of a new clinical trial for Profound, an innovative radiofrequency device clinically proven to improve facial and neck wrinkles without surgery. The current results suggest that with optimal settings, a Profound treatment can produce up to 89% of the laxity improvement results of a surgical facelift. With the new protocol for optimal settings to produce superior results, patients can realize many of the benefits approaching the surgical facelift with this novel minimally invasive in-office 30-minute treatment. The breakthrough technology meets the demands of today's consumers. In a recent survey, more than half of women with sagging jaw lines and "turkey necks" have considered nonsurgical treatment. Unlike facelifts, which require general anesthesia, long incisions, and recovery, Profound patients typically experience only minor redness that resolves within two to 12 hours and minimal swelling for up to five days. Most patients can resume normal activities within 24-48 hours.

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the disclaimer & terms of use